Palumbo-Wealth-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-22
Total Holdings
187
Total Value
299171959
Accession Number
0001951757-25-000421
Form Type
13F-HR
Manager Name
Palumbo-Wealth-Management
Data Enrichment
83% identified
155 identified32 unidentified

Holdings

187 positions • $299.2M total value
Manager:
Search and click to pin securities to the top
Page 10 of 10
00439U104
Shares:46.0K
Value:$104.9K
% of Portfolio:0.0% ($104.9K/$299.2M)
Verve Therapeutics, Inc.
Shares:15.8K
Value:$72.4K
% of Portfolio:0.0% ($72.4K/$299.2M)
Elevation Oncology, Inc.
Shares:278.0K
Value:$72.0K
% of Portfolio:0.0% ($72.0K/$299.2M)
Erasca, Inc.
Shares:43.3K
Value:$59.4K
% of Portfolio:0.0% ($59.4K/$299.2M)
Nautilus Biotechnology, Inc.
Shares:41.2K
Value:$35.4K
% of Portfolio:0.0% ($35.4K/$299.2M)
Ventyx Biosciences, Inc.
Shares:26.5K
Value:$30.5K
% of Portfolio:0.0% ($30.5K/$299.2M)
Inozyme Pharma, Inc.
Shares:29.8K
Value:$27.1K
% of Portfolio:0.0% ($27.1K/$299.2M)